Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

2017364 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 76, Issue 8, pp. 1340-1347

Field-Weighted Citation Impact: 35.79